Catalytic Wealth Ria, LLC Bristol Myers Squibb CO Transaction History
Catalytic Wealth Ria, LLC
- $545 Billion
- Q1 2025
A detailed history of Catalytic Wealth Ria, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Catalytic Wealth Ria, LLC holds 8,106 shares of BMY stock, worth $380,982. This represents 0.09% of its overall portfolio holdings.
Number of Shares
8,106
Previous 8,239
1.61%
Holding current value
$380,982
Previous $466 Million
6.09%
% of portfolio
0.09%
Previous 0.08%
Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,806Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.46 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.08 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.46 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.12 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.9B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...